GLG Partners LP - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 48 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
GLG Partners LP ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2013$10,570,000
+44.5%
8,610,000
+40.9%
0.96%
+244.8%
Q2 2013$7,317,0006,110,0000.28%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q2 2013
NameSharesValueWeighting ↓
TENOR CAPITAL MANAGEMENT Co., L.P. 36,001,000$95,697,00016.53%
CAPSTONE INVESTMENT ADVISORS, LLC 145,320,992$386,133,0006.28%
Verition Fund Management LLC 18,500,000$49,268,0005.72%
PIPER SANDLER & CO. 3,750,000$9,968,0004.14%
BERKLEY W R CORP 25,881,000$68,886,0003.58%
WOLVERINE ASSET MANAGEMENT LLC 31,256,000$83,048,0001.66%
TT INTERNATIONAL 760,000$2,020,0001.41%
FARALLON CAPITAL MANAGEMENT LLC 31,014,000$82,372,0001.20%
CSS LLC/IL 8,300,000$22,057,0001.12%
SG Americas Securities, LLC 370,000$98,536,0000.59%
View complete list of SALIX PHARMACEUTICALS INC shareholders